June 2017 | Volume 2

The number of infected total hip and knee replacement procedures combined is expected to reach 70,000 in 2020. That infection burden is expected to cost $1.6 billion.

Strong demand for 3D-printed products is a consistently-cited growth driver for Stryker, and in early 2017, leadership affirmed that a number of new 3D-printed products are slated for launch this year. The GE partnership will assist with machines and materials to ramp up manufacturing. 

FDA released 56 orthopaedic-related 510(k)s last month. Details on a locking plate, next-gen meniscus repair implant, SI joint fusion device and total hip are presented here.
Product adoption will take teams of teams--contract manufacturers, suppliers and service providers included--to meet today's purchasing demands.
EU Medical Device Regulation, Additive Manufacturing, Raw Materials, QMS, FDA Updates, DFM. These subjects and more are covered in presenter slides, available now.
Amedica announced preliminary 2016 revenue of $15.2MM, -22.2% vs. 2015. YTD 2017 highlights include a 12% increase in surgeon users and a 10% increase in sales agents vs. end of 2016.